Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ABHD10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100506473 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MLEC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF589 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PWP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC35F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SUPT7L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SRSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CADM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXA-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL7L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NNT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on